Safety, Tolerability and Efficacy of ICV AX 250 Treatment in MPS IIIB -OLE
NCT05492799
·
clinicaltrials.gov ↗
PHASE4
Phase
ENROLLING_BY_INVITATION
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
MPS III B
Interventions
DRUG:
AX 250
Sponsor
Allievex Corporation